|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA-Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Travis WD, Brambilla E, Muller-Hermelink
HK and Harris CC: World Health Organization Classification of
Tumours. Pathology and Genetics of Tumours of the Lung, Pleura,
Thymus and Heart. IARC Press; Lyon: 2004
|
|
3
|
Hanagiri T, Oka S, Takenaka S, et al:
Results of surgical resection for patients with large cell
carcinoma of the lung. Int J Surg. 8:391–394. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Battafarano RJ, Fernandez FG, Ritter J, et
al: Large cell neuroendocrine carcinoma: an aggressive form of
non-small cell lung cancer. J Thorac Cardiovasc Surg. 130:166–172.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang J, Yu JP, Yu WW, et al: Relationship
between VEGF expression and dendritic cells and regulatory T cell
distribution in large cell lung cancer. Zhongguo Zhong Liu Lin
Chuang. 39:1501–1504. 2012.(In Chinese).
|
|
6
|
Zhu R, Liu JM and Wang L: Clinical
analysis of 109 cases of large cell lung cancer. Linchuang
Zhongliuxue Zazhi. 17:912–914. 2012.
|
|
7
|
Kobold S, Völk S, Clauditz T, et al:
Interleukin-22 is frequently expressed in small- and large-cell
lung cancer and promotes growth in chemotherapy-resistant cancer
cells. J Thorac Oncol. 8:1032–1042. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khaghanzadeh N, Mojtahedi Z, Ramezani M,
Erfani N and Ghaderi A: Umbelliprenin is cytotoxic against QU-DB
large cell lung cancer cell line but anti-proliferative against
A549 adenocarcinoma cells. Daru. 20:692012. View Article : Google Scholar
|
|
9
|
Yousefi Z, Sarvari J, Nakamura K, et al:
Secretomic analysis of large cell lung cancer cell lines using
two-dimensional gel electrophoresis coupled to mass spectrometry.
Folia Histochem Cytobiol. 50:368–374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sabater-Marco V, García-García JA and
Roig-Vila JV: Basaloid large cell lung carcinoma presenting as
cutaneous metastasis at the colostomy site after abdominoperineal
resection for rectal carcinoma. J Cutan Pathol. 40:758–764. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun JM, Ahn MJ, Ahn JS, et al:
Chemotherapy for pulmonary large cell neuroendocrine carcinoma:
similar to that for small cell lung cancer or non-small cell lung
cancer? Lung Cancer. 77:365–370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lubin JH and Caporaso NE: Cigarette
smoking and lung cancer: modeling total exposure and intensity.
Cancer Epidemiol Biomarkers Prev. 15:517–523. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Xia Y, Li B, Gao N, et al: Expression of
tumor-associated calcium signal transducer 2 in patients with
salivary adenoid cystic carcinoma: Correlation with
clinicopathological features and prognosis. Oncol Lett.
8:1670–1674. 2014.PubMed/NCBI
|
|
14
|
Rekhtman N, Tafe LJ, Chaft JE, et al:
Distinct profile of driver mutations and clinical features in
immunomarker-defined subsets of pulmonary large-cell carcinoma. Mod
Pathol. 26:511–522. 2013. View Article : Google Scholar :
|
|
15
|
Buendia AJ, Sánchez J, Martinez CM and
Navarro JA: Immunohistochemical characterization of a pulmonary
large-cell carcinoma in a dog. Vet Pathol. 45:484–488. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stojsic J, Stevic R, Kontic M, et al:
Large cell lung carcinoma with unusual imaging feature,
immunophenotype and genetic finding. Pathol Oncol Res. 17:175–179.
2011. View Article : Google Scholar
|
|
17
|
Pardo J, Martinez-Peñuela AM, Sola JJ, et
al: Large cell carcinoma of the lung: an endangered species? Appl
Immunohistochem Mol Morphol. 17:383–392. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Barbareschi M, Cantaloni C, Del Vescovo V,
et al: Heterogeneity of large cell carcinoma of the lung: an
immunophenotypic and miRNA-based analysis. Am J Clin Pathol.
136:773–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Watanabe R, Ito I, Kenmotsu H, et al:
Large cell neuroendocrine carcinoma of the lung: is it possible to
diagnose from biopsy specimens? Jpn J Clin Oncol. 43:294–304. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Doddoli C, Barlesi F, Chetaille B, et al:
Large cell neuroendocrine carcinoma of the lung: an aggressive
disease potentially treatable with surgery. Ann Thorac Surg.
77:1168–1172. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mimae T, Yamashita M, Maeda A, et al:
Large cell neuroendocrine carcinoma of the lung. Kyobu Geka.
62:442–445. 2009.PubMed/NCBI
|
|
22
|
Gollard R, Jhatakia S, Elliott M and Kosty
M: Large cell/neuroendocrine carcinoma. Lung Cancer. 69:13–18.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tanaka Y, Ogawa H, Uchino K, et al:
Immunohistochemical studies of pulmonary large cell neuroendocrine
carcinoma: a possible association between staining patterns with
neuroendocrine markers and tumor response to chemotherapy. J Thorac
Cardiovasc Surg. 145:839–846. 2013. View Article : Google Scholar
|
|
24
|
Morbini P and Inghilleri S: Large-cell
lung carcinoma with basaloid architecture and neuroendocrine
differentiation: a new type of combined large-cell neuroendocrine
carcinoma. Int J Surg Pathol. 19:252–258. 2011. View Article : Google Scholar
|
|
25
|
Fournel L, Falcoz PE, Alifano M, et al:
Surgical management of pulmonary large cell neuroendocrine
carcinomas: a 10-year experience. Eur J Cardiothorac Surg.
43:111–114. 2013. View Article : Google Scholar
|
|
26
|
Rossi G, Cavazza A, Marchioni A, et al:
Role of chemotherapy and the receptor tyrosine kinases KIT,
PDGFRalpha, PDGFRbeta, and Met in large-cell neuroendocrine
carcinoma of the lung. J Clin Oncol. 23:8774–8785. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li H, Wang C, Yu J, et al: Dendritic
cell-activated cytokine-induced killer cells enhance the anti-tumor
effect of chemotherapy on non-small cell lung cancer in patients
after surgery. Cytotherapy. 11:1076–1083. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao Q, Zhang H, Li Y, et al: Anti-tumor
effects of CIK combined with oxaliplatin in human
oxaliplatin-resistant gastric cancer cells in vivo and in vitro. J
Exp Clin Cancer Res. 29:1182010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Saji H, Tsuboi M, Matsubayashi J, et al:
Clinical response of large cell neuroendocrine carcinoma of the
lung to perioperative adjuvant chemotherapy. Anticancer Drugs.
21:89–93. 2010. View Article : Google Scholar
|
|
30
|
Shimada Y, Niho S, Ishii G, et al:
Clinical features of unresectable high-grade lung neuroendocrine
carcinoma diagnosed using biopsy specimens. Lung Cancer.
75:368–373. 2012. View Article : Google Scholar
|
